http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Diabetes is the leading cause of new cases of blindness among adults 20 to 74 years old. Dr. Michael Grodin, co-director of retinal services and director of clinical research at Katzen Eye Group, with locations around Baltimore, discusses eye problems and the link to diabetes. http://medicalxpress.com/news/2012-11-diabetes-people.html Diabetes Fri, 30 Nov 2012 13:42:26 EST news273505339 (Medical Xpress)—Using a technique performed at Johns Hopkins but rarely elsewhere, imaging specialists and surgeons have successfully used precision, image-guided technology to glue shut a tangle of abnormal blood vessel growths in a 43-year-old woman's upper lip, face and nose. Surgery had earlier been ruled out because traditional approaches were considered too risky. http://medicalxpress.com/news/2012-11-woman-benefits-precision-guided-needle-dangerous.html Surgery Mon, 12 Nov 2012 07:16:29 EST news271926973 The primary treatment for wet macular degeneration, a chronic eye condition that causes vision loss, is effective even if patients have macular traction problems, a Mayo Clinic study shows. The findings will be presented today at the annual meeting of the American Academy of Ophthalmology in Chicago. http://medicalxpress.com/news/2012-11-age-related-macular-degeneration-treatment-eye.html Ophthalmology Sun, 11 Nov 2012 10:28:15 EST news271852068 (Medical Xpress)—A new drug developed by researchers from Flinders University, in partnership with collaborators in Melbourne, could hold the key to better treatment of some blinding eye diseases. http://medicalxpress.com/news/2012-11-drug-eye-disease.html Ophthalmology Thu, 01 Nov 2012 06:50:01 EST news270970718 (Medical Xpress)—For most of their natural lives, red blood cells hide safely under the radar of the body's immune system, thanks to a cloak of "don't eat me" protein called CD47. Ching-An Peng of Michigan Technological University wants to co-opt that clever trick to fight cancer. http://medicalxpress.com/news/2012-10-cd47-anti-cancer-drugs-tumor-cells.html Cancer Tue, 09 Oct 2012 09:29:29 EST news268993758 A Massachusetts General Hospital research team has identified factors that contribute to solid stress within tumors, suggesting possible ways to alleviate it, and has developed a simple way to measure such pressures. http://medicalxpress.com/news/2012-09-physical-block-cancer-treatment.html Cancer Thu, 20 Sep 2012 14:58:06 EST news267371873 There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that an oral nutriceutical, used on a last resort basis, rapidly restores vision to otherwise hopeless patients who face permanent loss. http://medicalxpress.com/news/2012-05-oral-agent-quell-invasive-macular.html Ophthalmology Sun, 06 May 2012 13:40:01 EST news255529398 At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of Health. http://medicalxpress.com/news/2012-04-avastin-lucentis-equivalent-age-related-macular.html Ophthalmology Mon, 30 Apr 2012 14:40:01 EST news255013861 (Medical Xpress) -- Every year, more than 200,000 people in the U.S. are diagnosed with Wet Age-Related Macular Degeneration, a leading cause of blindness in Americans age 60 or older. There is no known cure for the disease, which can lead to partial or complete vision loss. http://medicalxpress.com/news/2012-02-device.html Ophthalmology Wed, 29 Feb 2012 08:40:11 EST news249727184 A potential breakthrough in treating late-stage ovarian cancer has come from University of Guelph researchers who have discovered a peptide that shrinks advanced tumours and improves survival rates for this deadly but often undetected disease. http://medicalxpress.com/news/2011-11-discovery-late-stage-ovarian-cancer.html Cancer Wed, 16 Nov 2011 11:00:03 EST news240662556